Can a simple drug help lung cancer patients keep their strength?
NCT ID NCT07477808
First seen Mar 19, 2026 · Last updated May 02, 2026 · Updated 3 times
Summary
This study tests whether adding megestrol acetate (a drug that stimulates appetite) to standard cancer treatment helps malnourished patients with non-small cell lung cancer gain weight. About 116 adults with advanced lung cancer will be randomly assigned to receive either standard treatment plus megestrol or standard treatment alone. The main goal is to see if the drug improves body weight, with secondary goals of checking tumor response and survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.